Effects of resistance exercise in prostate cancer patients

Prostate cancer (PCa) is the most common malignancy in men [1] and shows the highest incidence rates of all cancer entities both in North America [2] and Austria [3]. It is responsible for the second most frequent cancer-related deaths in the USA [1, 2]; however, this is only because of the high absolute number of PCa patients, as the 5‑year and 10-year survival rates nowadays are well over 90% in developed countries [1, 4].

Although over 70% of men aged between 70 and 79 years will show histologic evidence of PCa, for the majority it is no longer the cause of death [1]. Therefore, for the majority of PCa patients their cancer has become a chronic, life-long, long-term disease. This increases the importance of supportive care in this patient population. A number of systematic reviews and meta-analyses have shown increases in quality of life [5], physical function and body composition [6] in PCa patients when conducting a resistance exercise (RE) program. From the perspective of exercise medicine RE is particularly beneficial for PCa patients as the side effects of their treatment often lead to a decrease in muscle mass and hence loss of physical function and increase of metabolic risk [7, 8] and RE is a potent intervention to counteract these complications [6].

Another major side effect of PCa treatment, particularly androgen deprivation therapy (ADT), is sexual dysfunction [9]. Sexual dysfunction finds its expression for the patients in decreased sexual desire, alone or together with erectile dysfunction, as well as absent orgasm [10]. The use of ADT is a major part of PCa treatment but alters men’s sexuality via loss of libido, the aforementioned erectile dysfunction, and testicular atrophy [11]. Treatment strategies for sexual dysfunction in PCa patients focus mainly on the treatment of erectile dysfunction after primary therapy; however, the sexuality issues of PCa patients are far more complex than erectile dysfunction alone and therefore require a multimodal treatment approach [12]. With its complex effects on various domains, such as physical fitness, quality of life, and perception of masculinity, RE has been proposed as a potentially effective treatment to maintain or even improve sexual health in PCa patients [13, 14].

Therefore, the primary aim of the current systematic review was to provide a systematic review update and qualitative overview about RE intervention trials in PCa patients published since 31 December 2016. The secondary aim was to draw particular attention to the outcome measures of parameters of sexual health in all RE intervention trials in PCa patients published to date.

A systematic search of the scientific literature published from January 1966 until 31 March 2020 was conducted in the scientific databases PubMed, EMBASE, MEDLINE, SCOPUS and Cochrane Library using the search terms and Boolean operators ((resistance AND exercise) OR (resistance AND training) OR (strength AND training)) AND ((prostate AND cancer) OR (androgen AND (deprivation OR suppression) AND therapy)). Only randomized, controlled trials (RCT) examining the effects of RE in patients with PCa, published in English, were considered for this review. As this is an update to a previously published systematic review [5] and a meta-analysis [6], the main focus was on the recent studies published since 1 January 2017. The search strategy was congruent to those of the previous review papers of our research group [5, 6].

Search results were screened by title and abstract. Eligible articles underwent a full-text analysis. The literature search as well as the selection of suitable articles was performed independently by two experienced researchers. The individual evaluations of those researchers were brought together and, in cases of an unequal evaluation, discussed with inclusion of the senior author until a mutual evaluation was decided on. The number of patients per study arm, most relevant patient characteristics, details of the intervention and reported outcomes were extracted from each included independent study and the corresponding registered protocol. Furthermore, reported outcomes were extracted from the identified additional articles.

Risk of bias was assessed for the original studies published since 1 January 2017 utilizing the revised Cochrane risk of bias tool (RoB 2, current version as of 22 August 2019) at the level of the primary outcome for both the intention-to-treat effect and the per protocol effect.

In addition, included articles from the current and our previous reviews were searched and reports of effects on sexual health were extracted.

This review was conducted following the PRISMA reporting guidelines for systematic reviews and meta-analyses.

Since January 2017, 10 articles have been published on the subject of RE in PCa patients: 5 independent studies and 3 additional articles expanded the evidence for the positive effects of RE on muscle strength, body composition, cardiovascular capacity, physical functioning and fatigue [47‐50, 52‐54, 57]. Of the independent studies two also indicated that a combination of RE and IT decelerated the loss of BMD during ADT.

Taaffe et al. [50] investigated the effects of an exercise intervention beginning approximately at the same time as ADT or 6 months later. The intervention, consisting of RE, aerobic exercise IT and stretching attenuated the loss of muscle mass and gain in fat mass. No effect on BMD was seen at 12 months, as it decreased in both groups; however, the partial cross-over design of the trial may have diminished the group differences. Even though the delayed intervention failed to attenuate the loss of BMD, it may be prudent to recommend an immediate initiation of exercise in this patient population, as bone metabolism is different and the recovery of BMD may be slower in older age [59].

The study by Galvao et al. [57] was the only one conducted in patients with metastatic disease. The exercise protocol, lasting 3 months and consisting of RE, aerobic exercise and stretching, was adapted for each patient, according to site of bone lesions. Due to difficulties in performing the majority of the tests, only complete cases were analyzed. The exercise intervention resulted in significant increases in muscular strength and self-reported physical functioning. Most probably, the clinically most important finding was the overall good acceptance and tolerance of the RE intervention. For this particular patient population, interventions affecting the risk of fractures and falls are of great interest. In a recent international cohort study on community-dwelling older men, the risk of a major osteoporotic fracture was negatively correlated with walking speed, grip strength and appendicular lean mass [60]. Furthermore, a recent systematic review found that interventions implementing RE, coupled with balance and functional exercises, probably reduced the risk of falls in older adults [61]. Whether these findings can be extrapolated to a reduced risk of fractures and falls in PCa patients with bone metastases remains to be determined, but there is currently little evidence to suggest otherwise.

Ndjavera et al. [48] implemented a 3-month exercise intervention of RE and interval aerobic exercise at the start of ADT, with a follow-up at 6 months. Improvements in fat mass, cardiovascular capacity, self-reported physical activity and HRQOL were observed, which further support the notion of concurrent ADT and exercise, similarly to the findings of Taaffe et al. [50].

Newton et al. [49] reported the results of a three-armed, one year-long RCT on PCa patients during ADT. In the study RE was combined either with aerobic exercise or IT and compared with a delayed intervention group. Bone loss was significantly slower in the RE + IT group at 6 months, but statistical significance was lost at 1 year for most sites. Interestingly, appendicular skeletal muscle mass improved only in the RE + IT group, even though both RE regimens resulted in an increase in muscle strength. The possibility of interference of RE and aerobic exercise, as well as additional loading due to IT were discussed by the authors.

Gazova et al. [47] presented the findings of a small RCT examining the effects of 16 weeks of isolated RE in PCa patients on ADT. The authors noted an improvement in muscle strength, cardiovascular capacity and, as a secondary outcome, an increase in the plasma concentration of myogenic miRNA. The study exhibited several potential methodological limitations. The sample size was small, comprising 15 patients in the intervention group and 8 in the control group, which may have increased the probability of a type II error [62]. Moreover, no sample size calculation was reported, which limits the ability to estimate the statistical power of the depicted results. The RE intervention was not sufficiently defined according to the FITT formula (Frequency, Intensity, Time and Type of exercise), which in turn reduces the detailed estimation of the RE stimulus as well as the reproducibility of the trial [63]. A total of 19 primary outcome measures were reported, alongside 3 secondary outcome measures. According to the CONSORT statement [64], a large number of primary outcomes increases the probability of a type I error; however, whether a type I or type II error truly occurred, cannot be determined at this time point [62]. Nevertheless, contrary to what one would expect of an RCT, the primary method of analysis used were within-group comparisons instead of between-group comparisons. This defeats the purpose of an RCT and increases the probability of a type I error [65].

Regarding the results of the additional articles, reported secondary outcomes indicated improvements in muscle strength [53, 54], cardiovascular capacity [52‐54], body composition [52], fatigue [52] and physical functioning [54]: however, the majority of the between-group comparisons showed no statistically significant differences. The reason for this might be that sample size calculations are always based on the primary outcome parameter which is normally published in the original article of a larger study. The secondary outcome parameters of additional articles can therefore never be treated with the same emphasis. These non-significant results are partly in line with the findings of our previous systematic review and meta-analysis [5, 6]. There, significant improvements in body composition, e.g. lean body mass and body fat, and in the 400m walk time could be found in the pooled results although the individual results of the vast majority of the pooled studies did not show significant results [6]. Pooling and therefore meta-analysis regarding fatigue and HRQOL was, and still is, impossible due to the high variability of outcome measures of these outcomes [66]; however, as RE is known to reduce cancer-related fatigue in general [67] as well as physical functioning in older adults [68], it is most probably a matter of time and not of validity before specific recommendations, concerning the implementation of RE to counteract fatigue in PCa patients can be made.

Sexuality and sexual health are an important aspect of life for a large proportion of people, even in old age, although to a lesser degree [69, 70]. Sexual bother, which is defined as distress caused by sexual dysfunction, and erectile dysfunction are highly prevalent in PCa patients, especially when the treatment includes ADT [13]. Furthermore, erectile dysfunction has been linked to depression in this patient population [71]. It is important to note that sexual bother is not purely a result of erectile dysfunction, as it can persist even after the return of erectile function [72]. Other factors negatively influencing sexual health include body feminization, fatigue, depression and a reduced HRQOL [73]. Moreover, the fat-free mass index has in itself been associated with sexual desire in middle-aged men [74]. Beside pharmacological interventions, exercise [13] and psychological counselling, the latter including education on alternative sexual practices [75], have been suggested as complementary therapeutic approaches. Despite the high prevalence and subjective disease burden of sexual dysfunction and the ever increasing commonness of RE interventions during ADT, only three studies [18, 34, 45] investigated the effects of RE on sexual function. Utilizing the EORTC QLQ-PR25, Cormie et al. [34] reported a significant increase in self-reported sexual activity and interest in sex following a 3-month RE and aerobic exercise intervention. Interestingly, the change in sexual activity correlated to perceived general health and role-emotional. The same research group reported the results of a second trial 1 year later [18], indicating positive effects of a similar exercise intervention on the HRQOL and in particular the self-reported sexual function, as measured by the same questionnaire. Lyons et al. [45] however, employed a different approach and examined the effects of a partnered RE intervention on self-reported physical intimacy in PCa patients and their spouses. The participants answered questions regarding affectionate, as well as sexual behavior on a 4-level Likert scale, as modified from Druley et al. [58]. Curiously, only the females reported an increase in affectionate behavior, and neither reported an increase in sexual behavior. Nevertheless, the results of these studies indicated positive effects on sexual health in PCa patients, and one drew the conclusion that future research should put more emphasis on this field. As it is understandable that side-effects of PCa therapy, such as fatigue, loss of muscle mass and pelvic floor disorders influence sexual health, it is possible that many of these symptoms persist due to a vicious cycle of weakness, fatigue and depression, being that greater muscle strength has been associated with lower fatigue in cancer survivors [76]. In this respect, RE, primarily with its effects on muscle mass and strength, including that of the pelvic floor [77], may provide an efficient therapeutic approach for sexual dysfunction in PCa patients. The optimal timing, dose and modality should be the subject of future research.

However, recommendations regarding physical activity are not always met in the general population, in particular as pertaining to RE, and this omission has been associated with greater deficits in the activities of daily living [78]. Although certain idiosyncrasies of cancer patients, especially those with bone metastatic disease, have to be considered [79], public awareness of the positive effects of exercise, including the socioeconomic impact, should be raised [80] in order to facilitate the application of the findings of clinical studies.

The limitations of this systematic review update are primarily twofold. Firstly, half of the articles published since 1 January 2017 presented additional data of independent articles. As mentioned before, the outcome parameters of additional articles cannot usually be graded with the same statistical weight as the original papers whose sample size had been calculated for the primary outcome measure in the first place and not for the additional outcomes. Therefore, the results of those articles generally must be treated with caution. Secondly, due to the sparse literature and heterogeneous assessment methods no meta-analysis of parameters of sexual health was possible. Future research should work toward closing this knowledge gap and thus enabling a meta-analysis of the cumulative data and formulation of concrete recommendations.

The results of this systematic review update expand the evidence for the efficacy of RE in the rehabilitation of PCa patients. Recent data also indicated that a combination of RE and IT has positive effects on BMD during ADT. Only a few studies have investigated the effects of RE on sexual health in this patient population. Considering their promising results, RE as a strategy to approach sexual health-related side effects in PCa patients is inadequately represented in the current literature and deserves a larger focus in future research.